For: | Hayes SJ, Hng KN, Clark P, Thistlethwaite F, Hawkins RE, Ang Y. Immunohistochemical assessment of NY-ESO-1 expression in esophageal adenocarcinoma resection specimens. World J Gastroenterol 2014; 20(14): 4011-4016 [PMID: 24744590 DOI: 10.3748/wjg.v20.i14.4011] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i14/4011.htm |
Number | Citing Articles |
1 |
Sima Ardalan Khales, Mohammad Reza Abbaszadegan, Ahmad Majd, Mohammad Mahdi Forghanifard. Linkage between EMT and stemness state through molecular association between TWIST1 and NY-ESO1 in esophageal squamous cell carcinoma. Biochimie 2019; 163: 84 doi: 10.1016/j.biochi.2019.05.016
|
2 |
Huiyu Wang, Datian Chen, Runjie Wang, Wen Quan, Dandan Xia, Jie Mei, Junying Xu, Chaoying Liu. NY-ESO-1 expression in solid tumors predicts prognosis. Medicine 2019; 98(48): e17990 doi: 10.1097/MD.0000000000017990
|
3 |
Soudeh Ghafouri-Fard. Expression of Cancer-Testis Antigens in Stem Cells: Is it a Potential Drawback or an Advantage in Cancer Immunotherapy. Asian Pacific Journal of Cancer Prevention 2015; 16(7): 3079 doi: 10.7314/APJCP.2015.16.7.3079
|
4 |
Yujie Zhang, Yuxin Zhang, Li Zhang. Expression of cancer–testis antigens in esophageal cancer and their progress in immunotherapy. Journal of Cancer Research and Clinical Oncology 2019; 145(2): 281 doi: 10.1007/s00432-019-02840-3
|
5 |
Afsheen Raza, Maysaloun Merhi, Varghese Philipose Inchakalody, Roopesh Krishnankutty, Allan Relecom, Shahab Uddin, Said Dermime. Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02306-y
|
6 |
Ali Esfandiary, Soudeh Ghafouri-Fard. New York Esophageal Squamous Cell Carcinoma-1 and Cancer Immunotherapy. Immunotherapy 2015; 7(4): 411 doi: 10.2217/imt.15.3
|